Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2025-12-24 @ 5:55 PM
NCT ID:
NCT00465868
Eligibility Criteria:
Inclusion Criteria:
* Men or women \> 18 years of age, non-child bearing potential
* First time acute myocardial infarction, as determined by evidence of transmural ischemia in the ECG and a rise in cardiac-Troponin-T (TNT) \> 0,1 (μg/l), followed by
* A successful acute PCI of a single vessel disease with a proximal/mid left anterior descent artery (LAD), circumflex artery (RCX) or right coronary artery (RCA) lesion (the index PCI).
Exclusion Criteria:
* Extensive cardiopulmonary resuscitation.
* Haemodynamically unstable patients, unable to leave the coronary care unit for the CMR examination.
* Use of fibrinolytics immediately prior to the index PCI.
* Significant primary valve disease,
* Autoimmune disease causing an increase in collagen turnover
* Active cancer disease
* Need for immunosuppressive treatment,
* Significantly reduced liver function
* Contraindications for performing a cardiac MRI-scan (claustrophobia, and implanted ferromagnetic devices, known allergic reactions to Omniscan™).
* Inability to understand the consent form or cooperate during the 1 year follow up.
* Comorbidity with poor prognosis.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00465868
Study Brief:
Protocol Section:
NCT00465868